<DOC>
	<DOCNO>NCT02459626</DOCNO>
	<brief_summary>StiffMAP-HFpEF trial investigator initiate , observational , single-center study evaluate whether fibrosis quantification cardiac MRI correlate leave right ventricular stiffness derive pressure-volume analysis , aim clarify cardiac MRI valid , non-invasive method ass diastolic function patient Heart Failure preserve ejection fraction .</brief_summary>
	<brief_title>Left Ventricular Stiffness vs. Fibrosis Quantification T1 Mapping Heart Failure With Preserved Ejection Fraction</brief_title>
	<detailed_description>Heart Failure preserve ejection fraction ( HFpEF ) diastolic dysfunction grow medical challenge . To date almost every second patient heart failure preserve ejection fraction recent data show outcomes patient bad reduced ejection fraction . In clinical routine diagnosis HFpEF complicate indirect assessment diastolic function . Mechanistically diastolic dysfunction among others believe cause development diffuse myocardial fibrosis increase extracellular matrix . Direct assessment intrinsic diastolic function stiffness ventricle obtain pressure-volume-curve tracing conductance catheter . Although offer benefit assess load-dependent load-independent parameter diastolic function well information contractility ventricular-arterial coupling , use technique limit invasiveness daily care . Newer MRI technique make possible quantify local fibrosis also diffuse fibrosis ( i.e . T1-Mapping ) determine extracellular volume . Moreover , role right ventricular function HFpEF well define . Aim current study therefore evaluate role MRI assess cardiac fibrosis context impaired LV diastolic function HFpEF patient , well evaluate role systolic diastolic right ventricular functional impairment patient cohort .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>LVEF &gt; 50 % Indication invasive cardiac catheterization know CAD CAD Angiography ( stenoses &gt; 50 % ) acute coronary syndrome Cerebral ischemia within last year contraindication MRI mild valvular disease Constrictive pericarditis , restrictive Cardiomyopathy , pericardial effusion pregnancy enrolment study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>